Skip to content
October 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Psychosocial Support and Mental Health
  • Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series
  • Psychosocial Support and Mental Health

Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series

Ali Ikhwan October 7, 2026 7 minutes read
navigating-the-post-treatment-journey-breast-cancer-canadas-october-education-series-1

As the landscape of oncology continues to evolve, the transition from active cancer treatment to long-term survivorship remains a critical, yet often daunting, phase for patients. Recognizing that the needs of those diagnosed with breast cancer extend far beyond the final infusion or surgical intervention, Breast Cancer Canada has launched a comprehensive October Education Series. Designed to empower patients with clinical knowledge, nutritional expertise, and emotional support, this series serves as a vital resource for those navigating the complexities of life after a breast cancer diagnosis.

Understanding Recurrence Risk: The Foundation of Post-Treatment Care

The series opened on October 1, 2026, with a flagship presentation by Dr. Nathalie Levasseur, a distinguished Medical Oncologist at BC Cancer. Focusing on the specific needs of patients living with HR+/HER2- early breast cancer, Dr. Levasseur addressed one of the most pressing questions in oncology: "What is my individual risk of recurrence?"

Clinical Factors and Genomic Precision

Dr. Levasseur emphasized that determining recurrence risk is no longer a one-size-fits-all process. Instead, it involves a sophisticated synthesis of clinical and pathological factors. During the session, she highlighted how modern genomic testing has revolutionized the way clinicians tailor treatment plans. By analyzing the unique genetic profile of a tumor, oncologists can better predict how aggressive a cancer might be and, crucially, how likely it is to return.

The discussion delved into the evolving treatment landscape, specifically the roles of endocrine therapy and CDK4/6 inhibitors. These treatments have significantly altered the prognosis for many, yet they also introduce a new set of long-term considerations. Dr. Levasseur provided attendees with a framework for evaluating these therapies, advising them on the essential questions they should pose to their care teams to ensure their treatment plan remains aligned with their evolving health status.

Addressing the Psychological Burden

Perhaps the most poignant aspect of the session was the focus on the "fear of recurrence" (FCR). For many survivors, the end of treatment marks the beginning of a new, complex psychological journey characterized by the uncertainty of the future. Dr. Levasseur acknowledged this pervasive anxiety, validating the experiences of patients who find that the silence following the completion of treatment can be as overwhelming as the noise of the diagnosis itself. By providing clinical context for this fear, the session aimed to move patients from a state of passive waiting to one of informed advocacy.

To view the recorded session or review the presentation slides, participants can access the Breast Cancer Canada digital archives.

Nutrition After Breast Cancer: Separating Myth from Science

The series continues on October 8, 2026, with a session led by Jean LaMantia, a Registered Dietitian and cancer survivor. In an era where "wellness influencers" often circulate contradictory advice, LaMantia’s session aims to provide a beacon of evidence-based clarity.

The Challenge of Nutritional Information

The sheer volume of online nutrition advice can be paralyzing for cancer survivors. Many patients are bombarded with conflicting information regarding "cancer-fighting diets," restrictive eating patterns, and supplement use, much of which lacks rigorous scientific backing.

LaMantia’s presentation is designed to cut through this noise by focusing on:

  • Protein and Muscle Maintenance: Critical for recovery and preventing muscle wasting.
  • Weight Management: Addressing the metabolic shifts that often occur during and after hormonal treatments.
  • Bone Health: A vital concern for patients undergoing long-term endocrine therapy, which can impact bone density.
  • Gut Health: Exploring the link between the microbiome, immunity, and overall vitality.

By offering a balanced approach that rejects unnecessary restrictions, the session encourages survivors to build a sustainable, nourishing relationship with food. The goal is to provide practical strategies that empower patients to reclaim control over their physical health without the stress of rigid, unproven dietary protocols.

Living Well: Addressing the Persistent Physical Effects

On October 15, 2026, the series shifts its focus to the physical reality of survivorship with a presentation by Voula Pantelis, a Breast Cancer Advocate and General Manager of AMOENA Canada.

Life Beyond the Medical Chart

"Treatment may end, but physical changes can continue," is the central tenet of Pantelis’s work. Many patients are unprepared for the long-term physical repercussions of their treatment, which can include chronic lymphedema, significant changes in body image, scar tissue sensitivity, and lingering discomfort.

Pantelis will guide attendees through a holistic approach to physical wellbeing, covering:

  • Surgical Recovery and Beyond: Managing long-term changes resulting from mastectomy or lumpectomy.
  • Compression and Lymphedema: Practical management strategies for those dealing with lymphatic issues.
  • Returning to Activity: Safely reintegrating physical exercise into daily life.
  • Navigating Daily Life: Including travel considerations and the psychological weight of visible and invisible scars.

This session serves as a crucial reminder that "survivorship" is an active process that requires ongoing physical maintenance and, at times, adaptation to a new normal.

Moving Emotions Forward: The "Root to Rise" Framework

The October series concludes on October 22, 2026, with a focus on emotional and existential health, led by Jacqueline Beatty, a breast cancer survivor and founder of Rising Lotus.

The Transition of Identity

The final session of the month acknowledges that the end of treatment is often a time of emotional upheaval. As the focus shifts from "fighting cancer" to "living life," many survivors struggle with shifting priorities, a loss of identity, and the complex process of reintegrating into the workplace and social spheres.

Beatty’s "Root to Rise" framework is designed to help participants navigate these transitions by fostering:

  • Self-Awareness: Identifying and acknowledging the complex emotions that follow a life-altering event.
  • Emotional Regulation: Developing tools to manage the waves of uncertainty that can arise months or even years after treatment.
  • Boundary Setting: Learning to prioritize personal needs in relationships and professional environments.
  • Values Alignment: Reconnecting with personal priorities to create a meaningful life post-diagnosis.

Implications for the Future of Cancer Care

The comprehensive nature of Breast Cancer Canada’s October Education Series highlights a paradigm shift in oncological care. No longer is the success of treatment measured solely by the absence of disease; it is increasingly defined by the quality of life, emotional resilience, and long-term functional health of the survivor.

Data-Driven Survivorship

The integration of medical oncology, nutritional science, physical therapy, and psychological counseling into a single, cohesive educational program suggests a growing recognition of the "whole-patient" approach. By providing these resources, Breast Cancer Canada is not only supporting individual patients but also contributing to a broader shift in the healthcare system toward survivorship-focused models.

Empowering the Patient Voice

The overarching theme of the October series is empowerment. By equipping patients with the language to discuss recurrence risk, the tools to manage long-term side effects, and the psychological frameworks to process their experience, Breast Cancer Canada is ensuring that patients remain the architects of their own health journeys.

As the 2026 series progresses, the organization continues to set a standard for patient advocacy, proving that the most effective way to improve outcomes is to ensure that every survivor has access to the information they need to thrive. Whether it is through the clinical expertise of Dr. Levasseur or the emotional guidance of Jacqueline Beatty, these sessions offer a roadmap for moving beyond the diagnosis and into a future of sustained health and wellness.


Upcoming Webinar Schedule:

  • Nutrition After Breast Cancer: October 8, 2026 | 1:00–2:00 p.m. ET
  • Living Well: Physical Effects Beyond Treatment: October 15, 2026 | 1:00–2:00 p.m. ET
  • Moving Emotions Forward: Root to Rise: October 22, 2026 | 1:00–2:00 p.m. ET

For registration details and further resources, visit the official Breast Cancer Canada website.

About the Author

Ali Ikhwan

Author

View All Posts

Post navigation

Previous: The Call for Consistency: Canadians Demand a National, Coordinated Strategy for Breast Cancer Care
Next: Strengthening Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership

Related Stories

bridging-the-divide-new-national-survey-reveals-urgent-call-for-standardized-breast-cancer-care-across-canada-2
  • Psychosocial Support and Mental Health

Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada

Nana October 7, 2026
bridging-the-divide-new-national-survey-calls-for-a-unified-standard-of-care-in-canadian-breast-cancer-treatment
  • Psychosocial Support and Mental Health

Bridging the Divide: New National Survey Calls for a Unified Standard of Care in Canadian Breast Cancer Treatment

Raul Delapena Setiawan October 7, 2026
a-system-at-a-crossroads-canadians-demand-radical-transformation-of-the-healthcare-landscape
  • Psychosocial Support and Mental Health

A System at a Crossroads: Canadians Demand Radical Transformation of the Healthcare Landscape

Jia Lissa October 7, 2026

Recent Posts

  • Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival
  • ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape
  • Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals
  • Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science
  • Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership Amid Crisis

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unveiling-a-cunning-cancer-strategy-how-triple-negative-breast-cancer-recruits-nerves-for-growth-and-survival
  • Medical Research and Clinical Trials

Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival

Iffa Jayyana October 7, 2026
arrivents-firmonertinib-fails-to-meet-primary-endpoint-in-nsclc-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape

Muslim October 7, 2026
navigating-the-intersection-glp-1-medications-and-breast-cancer-what-the-latest-research-reveals
  • Patient Advocacy and Support

Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals

Ammar Sabilarrohman October 7, 2026
research-as-the-cure-bcrf-transforms-grand-central-terminal-into-a-hub-of-hope-and-science
  • Patient Advocacy and Support

Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science

Siti Muinah October 7, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.